biotech · Alzheimer Disease · Friedreich Ataxia · LXEO
Lexeo Therapeutics
Lexeo Therapeutics clinical programs — 3 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
New York, USA HQ
2018 Founded
91 Employees
Public company Type
LXEO · NYSE Ticker
Company details
- Status
- Public
- HQ
- New York, USA
- Founded
- 2018
- Employees
- 91
- Programs
- 3
- Drugs
- 4
- Patents
- 0
Lexeo Therapeutics projects
3 ClinicalTrials.gov programs sponsored by Lexeo Therapeutics.
Lexeo Therapeutics has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does Lexeo Therapeutics have?
3 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.